Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis.

Hailian Lin, Kelang Wang, Kebing Zou, Yuanyuan Wang, Gen Xiang Que, Xuefeng Yang, Mengdan Liao

RetractedOpen access · hybridAbstract readRetracted Publication

In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

0.5field-weighted citation impact, top 43% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

MIWE: detecting the critical states of complex biological systems by the mutual information weighted entropy.BMC bioinformatics · 2024
Article
Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer.Cancers · 2023
Article
Retracted: Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis.Evidence-based complementary and alternative medicine : eCAM · 2023
Article

4 · The record

Corrections and comments

Retraction · 2023-07-19Concerns/Issues about Data · Concerns/Issues about Results and/or Conclusions · Concerns/Issues about Referencing/Attributions · Concerns/Issues about Peer Review · Informed/Patient Consent - None/Withdrawn · Investigation by Journal/Publisher · Investigation by Third Party · Lack of IRB/IACUC Approval and/or Compliance · Computer-Aided Content or Computer-Generated Content · Unreliable Results and/or Conclusions · · See also: https://pubpeer.com/publications/B7FE9551977C23E8398CF9F2E5DED8
Retracted
Retracted: Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis.2023

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hailian LinHunan Provincial Clinical Research Center for Metabolic Associated Fatty Liver Disease, the Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang 421002, Hunan, China.

Kelang WangHunan Provincial Clinical Research Center for Metabolic Associated Fatty Liver Disease, the Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang 421002, Hunan, China.

Kebing ZouHunan Provincial Clinical Research Center for Metabolic Associated Fatty Liver Disease, the Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang 421002, Hunan, China.

Yuanyuan WangHunan Provincial Clinical Research Center for Metabolic Associated Fatty Liver Disease, the Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang 421002, Hunan, China.

Gen Xiang QueHunan Provincial Clinical Research Center for Metabolic Associated Fatty Liver Disease, the Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang 421002, Hunan, China.

Xuefeng YangHunan Provincial Clinical Research Center for Metabolic Associated Fatty Liver Disease, the Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang 421002, Hunan, China.ORCID https://orcid.org/0000-0002-1555-4087

Mengdan LiaoThe Affiliated Nanhua Hospital, Department of Nephrology, Hengyang Medical School, University of South China, Hengyang 421002, Hunan, China.ORCID https://orcid.org/0000-0002-8473-9608

University of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colon adenocarcinoma (COAD) is one of the most common malignant tumors in clinics. It is often found at an advanced stage, with high incidence and poor prognosis; early diagnosis is difficult and treatment methods are limited. In order to find new methods for diagnosis and treatment of COAD, people pay more and more attention to the discovery and functional research of new oncogenes and tumor suppressor genes of COAD.

Identifiers

PMID35982994

DOI10.1155/2022/7264503

PMCPMC9381202

OpenAlexW4292432210

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.